Baidu
map

Int J Pediatr Otorhinolaryngol:生活方式相关的一些因素能够影响耳鼻喉疾病的患病率

2020-02-29 AlexYang MedSci原创

在最近几十年,研究人员注意到了久坐行为(SB)增加和身体活动(PA)减少的情况。最近,有研究人员确定了耳鼻喉疾病的发展与PA和SB之间的相关性。研究的数据来源于一个基于学校的关于小学、初中到高中儿童生活方式因素的调查研究。响应者会被提问SB、PA和耳鼻喉的情况:腺样体肥大(AH)、鼻窦炎(RS)和过敏性鼻炎(AR)。研究发现,清洁/吸尘的频率与AH的患病率有着显著的相关性。RS的患病率和工作日基于

在最近几十年,研究人员注意到了久坐行为(SB)增加和身体活动(PA)减少的情况。最近,有研究人员确定了耳鼻喉疾病的发展与PA和SB之间的相关性。

研究的数据来源于一个基于学校的关于小学、初中到高中儿童生活方式因素的调查研究。响应者会被提问SB、PA和耳鼻喉的情况:腺样体肥大(AH)、鼻窦炎(RS)和过敏性鼻炎(AR)。研究发现,清洁/吸尘的频率与AH的患病率有着显著的相关性。RS的患病率和工作日基于屏幕的活动显著相关。AR在那些不经常跑步、不经常参加团队运动、在上学日和周末花更少时间在户外以及在上学日花更多时间在电脑前的孩子中更为普遍。

最后,研究人员指出,他们的研究支持了PA、SB和耳鼻喉疾病患病率增加之间存在的联系。

原始出处:

Katarzyna Pazdro-Zastawny , Mateusz Kolator , Joanna Krajewska et al. Lifestyle-related Factors Differentiating the Prevalence of Otorhinolaryngological Diseases Among 6-17-year-olds From Wroclaw, Poland. Int J Pediatr Otorhinolaryngol. 05 Feb 2020.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1639373, encodeId=487f16393e33a, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Aug 31 17:44:00 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737004, encodeId=9ab21e370049c, content=<a href='/topic/show?id=e4bd8053614' target=_blank style='color:#2F92EE;'>#耳鼻喉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80536, encryptionId=e4bd8053614, topicName=耳鼻喉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b91734239731, createdName=ms5236388012055669, createdTime=Sun Aug 09 20:44:00 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728326, encodeId=b9281e28326e3, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Aug 11 19:44:00 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250671, encodeId=470212506e1cf, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Mon Mar 02 05:44:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379933, encodeId=983f3e9933e9, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Sat Feb 29 22:38:24 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379917, encodeId=842e3e9917fa, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Feb 29 15:52:46 CST 2020, time=2020-02-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1639373, encodeId=487f16393e33a, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Aug 31 17:44:00 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737004, encodeId=9ab21e370049c, content=<a href='/topic/show?id=e4bd8053614' target=_blank style='color:#2F92EE;'>#耳鼻喉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80536, encryptionId=e4bd8053614, topicName=耳鼻喉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b91734239731, createdName=ms5236388012055669, createdTime=Sun Aug 09 20:44:00 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728326, encodeId=b9281e28326e3, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Aug 11 19:44:00 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250671, encodeId=470212506e1cf, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Mon Mar 02 05:44:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379933, encodeId=983f3e9933e9, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Sat Feb 29 22:38:24 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379917, encodeId=842e3e9917fa, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Feb 29 15:52:46 CST 2020, time=2020-02-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1639373, encodeId=487f16393e33a, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Aug 31 17:44:00 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737004, encodeId=9ab21e370049c, content=<a href='/topic/show?id=e4bd8053614' target=_blank style='color:#2F92EE;'>#耳鼻喉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80536, encryptionId=e4bd8053614, topicName=耳鼻喉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b91734239731, createdName=ms5236388012055669, createdTime=Sun Aug 09 20:44:00 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728326, encodeId=b9281e28326e3, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Aug 11 19:44:00 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250671, encodeId=470212506e1cf, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Mon Mar 02 05:44:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379933, encodeId=983f3e9933e9, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Sat Feb 29 22:38:24 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379917, encodeId=842e3e9917fa, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Feb 29 15:52:46 CST 2020, time=2020-02-29, status=1, ipAttribution=)]
    2020-08-11 feather89
  4. [GetPortalCommentsPageByObjectIdResponse(id=1639373, encodeId=487f16393e33a, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Aug 31 17:44:00 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737004, encodeId=9ab21e370049c, content=<a href='/topic/show?id=e4bd8053614' target=_blank style='color:#2F92EE;'>#耳鼻喉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80536, encryptionId=e4bd8053614, topicName=耳鼻喉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b91734239731, createdName=ms5236388012055669, createdTime=Sun Aug 09 20:44:00 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728326, encodeId=b9281e28326e3, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Aug 11 19:44:00 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250671, encodeId=470212506e1cf, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Mon Mar 02 05:44:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379933, encodeId=983f3e9933e9, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Sat Feb 29 22:38:24 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379917, encodeId=842e3e9917fa, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Feb 29 15:52:46 CST 2020, time=2020-02-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1639373, encodeId=487f16393e33a, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Aug 31 17:44:00 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737004, encodeId=9ab21e370049c, content=<a href='/topic/show?id=e4bd8053614' target=_blank style='color:#2F92EE;'>#耳鼻喉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80536, encryptionId=e4bd8053614, topicName=耳鼻喉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b91734239731, createdName=ms5236388012055669, createdTime=Sun Aug 09 20:44:00 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728326, encodeId=b9281e28326e3, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Aug 11 19:44:00 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250671, encodeId=470212506e1cf, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Mon Mar 02 05:44:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379933, encodeId=983f3e9933e9, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Sat Feb 29 22:38:24 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379917, encodeId=842e3e9917fa, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Feb 29 15:52:46 CST 2020, time=2020-02-29, status=1, ipAttribution=)]
    2020-02-29 qingfengqishi5

    学习了,学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1639373, encodeId=487f16393e33a, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Aug 31 17:44:00 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737004, encodeId=9ab21e370049c, content=<a href='/topic/show?id=e4bd8053614' target=_blank style='color:#2F92EE;'>#耳鼻喉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80536, encryptionId=e4bd8053614, topicName=耳鼻喉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b91734239731, createdName=ms5236388012055669, createdTime=Sun Aug 09 20:44:00 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728326, encodeId=b9281e28326e3, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Aug 11 19:44:00 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250671, encodeId=470212506e1cf, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Mon Mar 02 05:44:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379933, encodeId=983f3e9933e9, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Sat Feb 29 22:38:24 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379917, encodeId=842e3e9917fa, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Feb 29 15:52:46 CST 2020, time=2020-02-29, status=1, ipAttribution=)]
    2020-02-29 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

相关资讯

盘点:耳鼻喉与遗传变异研究进展

【1】BMC Med Genet:巴西听力损伤群体SLC26A4基因变异分析 SLC26A4基因中的变异与彭德莱综合征和常染色体隐性遗传非综合症耳聋(DFNB4)相关。这两种障碍具有相似的听觉特性:双边听力损失,且为重度或者永久性,也许与内耳的异常相关,比如前庭水管的扩张或者蒙迪尼畸形。但是,在具有常染色体隐性遗传的彭德莱综合征中,除了先天性感官耳聋之外,甲状腺肿或者甲状腺功能紊乱也

口述|我是一个患了空鼻症的耳鼻喉科医生

我是一名耳鼻喉科医生,也是一位空鼻症患者。我经常给耳鼻喉科病人看病,却无法解决自己的鼻子问题。2003年秋,我在市里一家三甲医院学习时,不小心做了两场各一侧下鼻甲(编注:鼻甲是人体鼻腔外侧壁的精细器官,有上、中、下三个鼻甲,上鼻甲和中鼻甲是筛骨内侧壁的组成部分,下鼻甲为一单独的骨性器官。鼻甲有过滤空气、调节睡眠等功能。)手术,自此失去了人体鼻腔最重要的功能器官下鼻甲,鼻腔剩余黏膜逐渐失代偿,

耳鼻咽喉-头颈外科学分会:放眼世界,建立广泛的高级别的国际交流

中华医学会耳鼻咽喉头颈外科学分会遵照学会关于民主办会的精神,充分发动全体委员的智慧和力量,多年来在党建工作、组织建设、学科发展、人才梯队培养等方面开展了扎实深入且卓有成效的工作。特别是自2015年11月北京协和医院耳鼻咽喉科主任高志强教授接任分会主任委员以来,各项工作取得了跨越式的发展,尤其是在国际学术交流和合作方面成绩卓越。

盘点:耳鼻喉与遗传研究进展

【1】Cytokine:中国汉族人口中,与过敏性疾病位点和儿童过敏性鼻炎相关的16个全基因组关联研究相关性分析 过敏性鼻炎(AR)是儿童中最常见的呼吸道疾病之一。它是由遗传因素和环境因素组合引起的。中度到重度AR能够降低儿童的生活品质和社交表现。最近,有研究人员调查了是否已经报道的全基因组关联研究(GWAS)中的过敏性疾病位点的多样性与汉族儿童AR和AR症状严重度相关。研究发现,在E

J Craniofac Surg:电子烟对颅面区域的内黏膜影响研究

最近,研究人员一起耳鼻喉科学的角度调查了电子烟的相关影响,研究人员搜索了相关数据库,包括基里卡莱大学图书馆中央数据库、谷歌、PubMed、Proquest和谷歌学术等。研究发现,电子烟是一种以电池供电的设备,能够气化通常包括尼古丁的一种液体。目前,电子烟用来戒烟或者减少传统烟草香烟的消费。考虑到形状和大小,第一代电子烟与传统的烟草香烟相似,称为雪茄。与传统的烟草香烟通过燃烧产生烟雾不同,电子香烟包

Baidu
map
Baidu
map
Baidu
map